S&P 500   2,997.56 (-0.01%)
DOW   26,982.43 (-0.16%)
QQQ   193.48 (+0.04%)
AAPL   234.93 (+0.26%)
FB   190.71 (+0.55%)
MSFT   139.72 (+0.18%)
GOOGL   1,257.78 (+0.31%)
AMZN   1,784.43 (-0.33%)
CGC   20.32 (+0.05%)
NVDA   194.34 (+0.90%)
MU   44.44 (-2.20%)
BABA   175.42 (-0.47%)
GE   9.01 (-0.55%)
TSLA   259.18 (-1.23%)
AMD   31.29 (+0.87%)
T   38.05 (+0.71%)
F   9.17 (+0.77%)
ACB   3.80 (+0.00%)
PRI   123.89 (-0.06%)
NFLX   286.66 (-2.28%)
BAC   30.30 (+0.76%)
GILD   65.17 (+0.02%)
DIS   132.81 (-0.04%)
S&P 500   2,997.56 (-0.01%)
DOW   26,982.43 (-0.16%)
QQQ   193.48 (+0.04%)
AAPL   234.93 (+0.26%)
FB   190.71 (+0.55%)
MSFT   139.72 (+0.18%)
GOOGL   1,257.78 (+0.31%)
AMZN   1,784.43 (-0.33%)
CGC   20.32 (+0.05%)
NVDA   194.34 (+0.90%)
MU   44.44 (-2.20%)
BABA   175.42 (-0.47%)
GE   9.01 (-0.55%)
TSLA   259.18 (-1.23%)
AMD   31.29 (+0.87%)
T   38.05 (+0.71%)
F   9.17 (+0.77%)
ACB   3.80 (+0.00%)
PRI   123.89 (-0.06%)
NFLX   286.66 (-2.28%)
BAC   30.30 (+0.76%)
GILD   65.17 (+0.02%)
DIS   132.81 (-0.04%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AlectorAerie PharmaceuticalsTwist BioscienceOrchard TherapeuticsNanoString Technologies
SymbolNASDAQ:ALECNASDAQ:AERINASDAQ:TWSTNASDAQ:ORTXNASDAQ:NSTG
Price Information
Current Price$15.20$20.61$24.77$12.63$21.92
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$26.67$61.36$26.33$25.14$35.00
% Upside from Price Target75.44% upside197.74% upside6.30% upside99.07% upside59.67% upside
Trade Information
Market Cap$1.01 billion$931.65 million$763.18 million$1.11 billion$779.06 million
BetaN/A0.53N/AN/A1.19
Average Volume556,0451,438,088250,578165,619444,023
Sales & Book Value
Annual Revenue$27.51 million$24.18 million$25.43 million$2.08 million$106.73 million
Price / Sales38.0339.1631.71584.087.28
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book ValueN/A$5.01 per shareN/A$3.63 per share$1.20 per share
Price / Book4.113.4818.27
Profitability
Net Income$-52,250,000.00$-232,570,000.00$-71,230,000.00$-230,490,000.00$-77,400,000.00
EPS($4.62)($4.65)($25.51)($10.22)($2.78)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-478.81%-204.63%N/A-68.16%
Return on Equity (ROE)N/A-89.52%-168.45%N/A-118.03%
Return on Assets (ROA)N/A-69.25%-61.41%N/A-42.27%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.17%0.08%0.03%0.07%1.27%
Current Ratio6.18%2.52%7.18%7.89%5.21%
Quick Ratio6.18%2.35%6.96%7.89%4.76%
Ownership Information
Institutional Ownership Percentage40.52%N/A42.69%63.00%99.95%
Insider Ownership Percentage34.40%8.71%29.40%N/A5.10%
Miscellaneous
Employees91353289180476
Shares Outstanding68.83 million45.94 million32.56 million96.19 million35.44 million
Next Earnings Date11/11/2019 (Estimated)11/5/2019 (Estimated)12/18/2019 (Estimated)N/A11/4/2019 (Confirmed)
OptionableNot OptionableOptionableNot OptionableNot OptionableOptionable
 AlectorAerie PharmaceuticalsTwist BioscienceOrchard TherapeuticsNanoString Technologies

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel